Interventions for cutaneous disease in systemic lupus erythematosus-Reference-Cited by-同舟云学术

Interventions for cutaneous disease in systemic lupus erythematosus

Published:2021-03-09 Issue:3 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hannon Cora W¹,McCourt Collette²,Lima Hermenio C³,Chen Suephy⁴,Bennett Cathy⁵

Affiliation:

1. Dermatologist, Masters of Public Health Program; Harvard School of Public Health; Boston Massachusetts USA

2. Department of Dermatology; Royal Victoria Hospital; Belfast UK

3. Department of Dermatology, Clinical Unit for Research Trials and Outcomes in Skin (CURTIS); Massachusetts General Hospital; Boston Massachusetts USA

4. Emory University Hospital; Emory Healthcare; Atlanta Georgia USA

5. Office of Research and Innovation; Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn; Dublin Ireland

Publisher

Wiley

Subject

Pharmacology (medical)

Reference287 articles.

1. Efficacy of rituximab versus cyclophosphamide in lupus patients with severe manifestations: a randomized and multicenter study;Andrade-Ortega;Reumatologia Clinica,2010

2. Double-blind randomized controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus;Bezerra;Arthritis and Rheumatism,2005

3. Prevention of relapses in systemic lupus erythematosus;Bootsma;Lancet,1995

4. Double blind, randomized controlled, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus;Carneiro;Journal of Rheumatology,1999

5. Efficacy and safety of epratuzumab in patients with moderate to severe systemic lupus erythematosus: results from two phase-3, placebo controlled trials;Clowse;Arthritis and Rheumatology,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolite‐derived damage‐associated molecular patterns in immunological diseases;The FEBS Journal;2023-07-25

2. Deuterium in drug discovery: progress, opportunities and challenges;Nature Reviews Drug Discovery;2023-06-05

3. Current treatment of systemic lupus erythematosus: a clinician's perspective;Rheumatology International;2023-05-12

4. Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects;Anais Brasileiros de Dermatologia;2023-05

5. Nanobodies: A Review of Generation, Diagnostics and Therapeutics;International Journal of Molecular Sciences;2023-03-22